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Abstract Protein kinase CK2 (casein kinase 2) is a ubiquitous 
Ser/Thr protein kinase involved in cell proliferation. Mutation of 
the a subunit of the Xenopus laevis CK2 to change aspartic acid 
156 to alanine (CK2aA156) resulted in an inactive enzyme. The 
CK2aA156 mutant, however, binds the regulatory subunit as 
measured by retention of J3 on a nickel chelating column 
mediated by (His)6-tagged CK2aA
156. Addition of CK2aA156 
also caused j3 to shift sedimentation in a sucrose gradient from a 
& dimer (52 kDa) to an aaft tetramer (130000 kDa). 
CK2ccA156 can trap the /J subunit in an inactive complex 
reducing the stimulation of casein phosphorylation caused by 
addition of J3 to wild-type a. This competitive effect depends on 
the ratio of orfaA158 and on the amount of /5 available. Since /} 
inhibits the phosphorylation of calmodulin by CK2a, the addition 
of CK2aA156, in this case, increases calmodulin phosphorylation 
by the a and /3 combination. These results suggest that 
CK2aA156 may be a useful dominant-negative mutant that can 
serve to explore the multiple functions of CK2J3. 
© 1997 Federation of European Biochemical Societies. 
Key words: Protein kinase CK2; Casein kinase II; 
CK2cc subunit mutant; CK2(3 subunit; 
Dominant-negative mutant 
1. Introduction 
Protein kinase CK2 (also known as casein kinase II) is a 
ubiquitous Ser/Thr protein kinase known to phosphorylate 
many important protein substrates (reviewed in Refs. [1-3]). 
CK2 is composed of catalytic subunits a and a', which 
although closely analogous, are coded by different genes. 
The CK2 subunits a (Mr 44000) and a ' (Mr 40000) are active 
by themselves but their activity and stability are markedly 
altered by the presence of the P subunit which binds to 
form heterotetramers of OC2P2, oca'P2 and oc'2P2 composition 
[4,5]. With the majority of the substrates, the addition of P 
subunit increases the phosphorylating activity of oc; however, 
in the phosphorylation of calmodulin by a, the P subunit acts 
as a negative regulator [6,7]. 
There is much evidence indicating that CK2 is involved in 
the process of cell division. The levels of CK2 in growing and 
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tumor tissues is greatly enhanced [8]. Introduction of the 
CK2oe gene in transgenic mice demostrated its capacity to 
act as an oncogene complementary to myc [9]. The microin-
jection of CK2 antisense RNA or antibodies indicates that 
CK2 is required for Gl/S and G2/M cell cycle transition in 
cultured mammalian cells [10,11]. Similar conclusions have 
been reached using thermosensitive mutants of the CK2a sub-
unit in yeast [12]. Very recently, yeast two-hybrid analysis has 
been used to demonstrate the interaction of CK2P with A-Raf 
[13,14] and with mos [15]. Both A-Raf and mos are cytoplas-
mic oncogene products that have Ser/Thr protein kinase ac-
tivity that phosphorylate and activate MEK and are therefore 
involved in the transduction of the stimuli that trigger cell 
division. CK2 also binds to p53 and p 2 1
W A F / C I P [16,17] which 
are well characterized repressors of cell division. Despite this 
evidence pointing to a prominent role for CK2 in many key 
cell processes, the question as to the mechanisms that phys-
iologically regulate CK2 activity remains open. 
A number of studies have dealt with the structure and 
function of this enzyme through site directed mutagenesis. 
These studies have indicated that the carboxyl end of the P 
subunit is important for its interaction with the a subunit and 
that the acidic cluster of amino acids (55-64) of this subunit 
down-regulates the enhancing capacity of P for a [18,19]. 
Mutations in the a subunit have pinpointed the region re-
sponsible for polyanionic inhibitor binding to the basic region 
including amino acids 71-78 [20] and provided information as 
to the residues involved in peptide substrate recognition [21]. 
Other mutations in a subunit have explored the mode of 
activation used by P subunit and the interaction with ATP 
and GTP [22]. 
The important structural information derived from the 
known tridimensional structure of other members of the fam-
ily of protein kinases has made it possible to predict the func-
tion of some amino acid residues present in the CK2a struc-
ture. Thus, the aspartic acid residue in position 156 of CK2a 
occupies a position similar to aspartic acid 166 in the cyclic 
AMP-dependent protein kinase (PKA), where this aspartic 
acid plays a key role in the catalysis of phosphoryl group 
transfer [23]. 
In the present study we report results obtained with a Xen-
opus laevis CK2a mutant in which aspartic acid 156 is 
changed to alanine. As expected from the homology to 
PKA, the mutant protein has no phosphorylating activity. 
The mutants does, however, retain high affinity for the 
CK2P subunit. The CK2aA15e mutant can efficiently compete 
with the wild-type CK2oc for the regulatory p subunit and 
may therefore be a useful "dominant negative" type of muta-
tion that can serve to explore the cellular function of CK2 
subunits in vivo. 
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2. Experimental procedures 
2.1. Materials 
Nucleotide oligomers and peptides were synthesized by Oligopepti-
do, the core facility of the University of Chile. [y-32P]ATP was pur-
chased from ICN. Restriction enzymes and Taq polymerase were 
obtained from Promega. GSH-agarose was from Pharmacia and ni-
trilotriacetic acid (NTA) agarose from Invitrogen. Glutathione, de-
phospho-p-casein, calmodulin, thrombin and remaining reagents 
were from Sigma. 
2.2. Methods 
2.2.1. Preparation of pT7-7H6. To facilitate expression and puri-
fication of CK2a and mutant subunits, a vector including a (His)6 tag 
was prepared by inverse PCR of plasmid pT7-7 using the primers: (5'-
ATATATATATACATATGATGATGATGATGATGCATATCTC-
CTTCTTAAAGTT-3') and (5'-TATATACATATGGCTAGAATT-
3'). The product was digested with Ndel and self-ligated to reestablish 
the plasmid. Effective incorporation of the tag was confirmed by 
DNA sequencing. 
2.2.2. Preparation of CK2aA156. The point mutation was intro-
duced into wild-type CK2a cDNA clones in pT7-7 by PCR overlap-
ping primer extension [24]. Initial PCRs were conducted with the 
following primer pairs: (5'-TAATGCACAGAGCTGTGAAACC-
TC-3') and the T7 primer (5'-AATACGACTCACTATAG-3') and 
with (5'-GAGGTTTCACAGCTCTGTGCATTA-3'), and reverse T7 
primer (5'-ATTGGTAACTGTCAGACCAAG-3). 
For the last amplification reaction the T7 and reverse T7 primers 
were used. 
The product was digested with Ndel and Sail and subcloned into 
pT7-7H6. The complete sequence of the mutated recombinant con-
struct was confirmed by sequencing. 
2.2.3. Expression and purification of recombinant CK2 sub-
units. The cDNAs coding for the CK2 subunits a and P were ob-
tained as previously described [25]. CK2a', subcloned in pT7-7, was 
expressed as described [26]. CK2a and CK2aA156 were ligated into 
the expression vector pT7-7H6 and expressed in E. coli strain BL21 
(DE3). These latter proteins were purified by passing the supernatant 
fraction of bacterial extracts through a 3 ml nickel-chelate NTA-agar-
ose column, previously equilibrated with buffer A (50 mM Tris-HCl 
pH 8, 20 mM P-mercaptoethanol, 100 mM NaCl, 1 mM phenylmeth-
ylsulfonyl fluoride), washed with the same buffer and eluted with a 
linear gradient, 10-200 mM imidazole in buffer A with 10% glycerol. 
The elution of CK2oc was checked by activity and SDS-gel electro-
phoresis while the elution of the inactive CK2aA156 was followed by 
electrophoresis and Western blot using a polyclonal antibody specific 
for CK2a [27]. The purified preparations of CK2a and a ' used had a 
specific activity of 67 and 42, nmol 32P incorporated into casein/min 
per mg, respectively. 
The recombinant CK2p subunit, subcloned in pGEX-2T vector, 
was expressed as previously described [25]. The fusion protein was 
purified by chromatography of GSH-agarose, treated with thrombin 
and rechromatographed on GSH-agarose. 
2.2.4. Preparation of native CK2 holoenzyme. Stage VI oocytes 
were isolated from Xenopus laevis ovary and extracts prepared by 
hand-homogenizing 50 oocytes in 1 ml of buffer B (50 mM HEPES, 
pH 8.0; 10 mM MgCl2; 1 mM dithiothreitol; 10 mM benzamidine, 
5 mM phenylmethylsulfonyl fluoride and 10% glycerol). Homogenates 
were centrifuged at 14000 rpm (Sorvall Microspin 24S rotor) and the 
supernatant solution was adjusted to 0.25 M NaCl and applied to a 
0.5 ml column of phosphocellulose equilibrated with a 0.25 M NaCl 
in buffer B. After washing with 10 vol. of the same solution, CK2 was 
eluted with 0.5 ml of 0.7 M NaCl in buffer B. 
2.2.5. Preparation of [32P]CK2$ subunit. CK2P (40 pmol) was 
incubated in the presence of 2.7 u.Ci of [y-32P]ATP, 0.8 pmol of 
CK2a, 50 mM HEPES pH 7.5 and 10 mM MgCl2, in a final volume 
of 60 |il. Incubation was for 30 min at 30°C. The reaction mixture was 
cooled to 4°C and applied to a 0.1 ml column of nickel NTA-agarose, 
which retains the (His)6-tagged CK2a subunit and a stoichiometric 
amount of CK2p. The column was washed with a minimum of equil-
ibration buffer A to remove the unbound phosphorylated CK2P sub-
unit which was measured by precipitation in 10% trichloroacetic acid 
and collecting precipitates on GF/A filters for counting in a scintilla-
tion system. A typical preparation contained 10000 cpm/pmol of 
CK2p. 
2.2.6. Analysis of CK2 subunits on sucrose density gradients. CK2 
subunits alone or in the combinations indicated were adjusted to 0.3 
M NaCl and 0.1% Triton X-100 preincubated for 45 min at 4°C and 
200 ul applied to a 5 ml lineal gradient of 5-20% sucrose containing 
buffer C (50 mM HEPES, pH 7.5, 10 mM MgCl, 0.3 M NaCl, 0.5 uM 
dithiothreitol and 0.1% Triton X-100), followed by centrifugation at 
40000Xg for 13 h at 4°C. Fractions were collected and aliquots 
analyzed for acid precipitable radioactivity as given above. 
2.2.7. Protein kinase assay of the recombinant subunits and native 
holoenzyme. The standard assay mixture contains in a total volume 
of 30 ul: 50 mM HEPES pH 7.5, 100 mM NaCl, 10 mM MgCl2, 0.5 
mM dithiothreitol, 50 uM [y-32P]ATP (500-2000 cpm/pmol) and ei-
ther 5 mg/ml casein or 0.3 mM peptide substrate RRREEEESEEE. 
CK2 subunits were added as indicated. Incubations were carried out 
for 10 min at 30°C and the reaction was terminated by applying 25 u.1 
to P81 phosphocellulose filter paper, as described [25]. 
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Fig. 1. Binding of CK2aA156 to the CK2P subunit. A: 1 pmol each 
of CK2a (•), CK2aA156 (■), or buffer A alone (X) were applied to 
separate 0.2 ml columns of NTA-agarose and the columns were 
washed extensively with buffer B to remove any unbound protein. 
[32P]CK2p (20000 cpm) prepared as described in Section 2.2 was 
passed through each column and then washed with 3 ml of buffer 
B. The resulting complexes were eluted with 200 mM imidazole in 
buffer B. Fractions of 0.2 ml were collected and 0.1 ml analyzed for 
radioactivity by precipitation with 10% trichloroacetic acid and re-
tention of protein of GFA glass fiber filters. B: sedimentation pro-
files were obtained with sucrose gradients (5-20% in buffer C), cen-
trifuged as given in Section 2. The gradient tubes contained 1 pmol 
of [32P]CK2P ( ~ 10000 cpm) to which was added 5 pmol of CK2a 
(•), 5 pmol of CK2aA156 (■) or buffer C alone (o)- Fractions were 
analyzed for radioactivity as given in A. Protein standards with 
known sedimentation coefficients were catalase (232 kDa), and bo-
vine serum albumin (BSA; 67 kDa) indicated by arrows. 
D. Cosmelli et al.lFEBS Letters 410 (1997) 391-396 393 
3. Results 
3.1. CK2aAlx binds to the CK2§ subunit 
The recombinant CK2aA156 mutant and the wild-type 
CK2cc subunit were expressed in bacteria as (HisVtagged 
proteins and purified on a nickel-chelate NTA-agarose col-
umns. The mutant protein was shown to have the same mo-
lecular size and antigenic properties as the Xenopus laevis 
CK2oc subunit (not shown). However, when CK2aA156 was 
analyzed for activity with casein or the specific substrate pep-
tide, it was completely inactive in its phosphorylating ca-
pacity. 
Considering the importance of subunit interaction for the 
regulation of CK2 activity, the interaction of this mutant 
form with the CK2(3 subunit was analyzed. It was found 
that CK2ocA156 can efficiently bind the p subunit. In Fig. 
1A it is seen that (His)6-tagged CK2ocA156 can mediate the 
retention of [32P]CK2fj on an NTA-agarose affinity column 
and that the radioactivity of P is eluted with imidazole in the 
same position as that seen for the wild-type (HisVtagged 
< Ot 
o 
pmoles of aA ' 
Fig. 2. CK2exA156 inhibits the activation of the CK2a subunit by 
CK2|3. A: 1 pmol of each CK2a and CK2|3 was assayed in the 
presence of varying concentrations of CK2aA156, under standard 
conditions, with P-casein as substrate. The basal activity of CK2a 
in this experiment was 0.2 pmol/min of [32P] incorporated into pro-
tein (arrow); the maximal activation by CK2P was 5.5-fold (1.1 
pmol/min). B: CK2a subunit (1 pmol) was assayed in the presence 
(■) or absence (•) of a 6-fold excess of CK2ceA156 and with differ-
ent concentrations of the CK2P subunit, using the standard condi-
tions given in the Section 2 with P-casein as substrate. 
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Fig. 3. Effect of preincubation of a and P subunits. CK2 subunits 
(1 pmol of a, 6 pmol of CK2aA156, and 1 pmol of P) were preincu-
bated (preinc.) in the combinations indicated in the figure for 10 
min at 0°C before adding the third component (inc.) and then as-
sayed under standard conditions using P-casein (closed bars) or syn-
thetic peptide (open bars) as substrates. In 5, the aA156 A indicates 
that this subunit was heated at 100°C for 5 min before the assay. 
CK2a subunit. The elution of active CK2cc was determined 
by assay of the column fractions and the position of the a and 
P subunits was confirmed by SDS-polyacrylamide gel electro-
phoresis (not shown). 
An alternative method to demonstrate the interaction of 
CK2aA156 with CK2p was the use of sedimentation analysis 
in sucrose gradients, where a shift in sedimentation of the P 
subunit would be expected if such interaction does occur. The 
[32P]CK2P subunit, in the absence of other proteins, sediments 
as a dimer with a molecular mass of 52 kDa (Fig. IB). The 
addition of either CK2ocA156 or CK2a causes a large fraction 
of the labeled P subunit to shift to a sedimentation value 
calculated as 130 kDa, which corresponds to the expected 
value for the CC2P2 tetramer. 
3.2. Competition of CK2aA156 with CK2a for the CK2$ 
subunit 
The capacity of CK2aA156 to bind p can also be observed 
by its inhibitory effect in the protein kinase assay, in which the 
mutant subunit is added simultaneously with the a and P 
subunits. In Fig. 2A an assay is described in which casein 
phosphorylation is measured and it is seen that increasing 
amounts of CK2ocA156 inhibit the activation of the wild-type 
CK2a by p approaching complete inhibition of the effect 
when a 10-fold excess of mutant is present. From the molar 
amounts of the wild-type and mutant subunits used, it can be 
estimated that the affinity of CK2ocA156 for p is approximately 
50% of the affinity of the wild-type protein. Similar experi-
ments carried out with the recombinant wild-type CK2a' sub-
unit demonstrate that aA156 can also compete with this iso-
form for the P subunit (not shown). Fig. 2B shows that when 
CK2aA156 is present in the assay system in 6-fold excess over 
CK2oc and increasing amounts of CK2P are tested for activa-
tion of oc, the mutant subunit does not itself inhibit CK2oc 
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Fig. 4. CK2aA156 reverses the inhibitory effect of CK2B on calmodulin phosphorylation and inhibits autophosphorylation of CK2B by CK2oc. 
A: the standard kinase assay was used except that incubations were for 10 min (odd numbers) and 30 min (even numbers) and 60 pmol of 
calmodulin was used as substrate. Subunit amounts were: 1 pmol CK2oe, 5 pmol CK2a156 and 1 pmol CK2B, where indicated. Phosphorylated 
proteins were resolved on a 13% SDS polyacrylamide gel and visualized by autoradiography. The migration of calmodulin and P subunit are 
indicated by arrows. B: CK2 subunits, 1 pmol CK2cc, 5 pmol CK2 aA156, and 1 pmol B, were preincubated and incubated in the combinations 
indicated below the figure. Preincubations were for 10 min at 0°C. The resulting phosphoproteins were analyzed as in A. Arrows indicate the 
migration of the individual subunits and a contaminating fusion protein glutathione transferase CK2B. The migration of size standards are giv-
en in kDa. 
basal activity and significant activation becomes evident only 
when the level of p is roughly equivalent to the amount of the 
mutant protein. Further increase of the CK2(3 concentration 
permits proportionaly increased activation of the phosphoryl-
ation reaction. 
In the previous experiments, the CK2(3 subunit was added 
to the reaction mixture which already contained a mixture of 
the native and mutant a subunits, so that the competing sub-
units might form their respective complexes simultaneously. It 
was pertinent therefore to determine whether preincubation of 
CK2|3 with either of the CK2cx subunits would affect the 
activation reaction. In Fig. 3, in which the activity is assayed 
with the peptide substrate and with casein, it can be observed 
that preincubation at 0°C of the a and (3 subunits (condition 
2) results in a lower inhibition than when both a and aA156 
react with P at the same time (condition 3). Conversely pre-
incubation of aA156 with P increases significantly the compet-
itive inhibitory effect (condition 4). Heating the aA156 at 
100°C for 5 min (condition 5) destroys its inhibitory activity. 
It is noteworthy that no inhibition was observed when na-
tive CK2 holoenzyme prepared from Xenopus laevis oocyte 
extracts [28] is tested under the standard assay conditions 
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and with an amount of mutant protein calculated to be an 
excess of the OC2P2 concentration. 
The effect of the mutant on the phosphorylation of calm-
odulin and of the B subunit itself was also studied. As seen in 
Fig. 4A, the presence of the CK2aA156 reverses the inhibitory 
effect that B has on calmodulin phosphorylation by the wild-
type a subunit of CK2. In Fig. 4B we see that addition of 
CK2aA156 decreases the phosphorylation of the B subunit and 
that preincubation of ocA156 with B diminishes even further 
this phosphorylation. 
4. Discussion 
The mutation of aspartic acid 156 of the a subunit of pro-
tein kinase CK2 to alanine results in complete loss of catalytic 
activity. This result confirms the recurrent observation that all 
kinases which share the conserved features first described in 
PKA have very similar structural arrangements that are essen-
tial for their catalytic function [29]. 
The most significant results obtained with CK2ocA156, on 
the other hand, demonstrate the capacity of this inactive mu-
tant to bind the B regulatory subunit of CK2. This capacity to 
complex B is demonstrated through direct physical interaction 
studies that show that CK2aA156 with a (His)e tag can medi-
ate the retention of radioactive B in a metal chelate NTA-
agarose affinity column. In addition, the CK2rxA156 subunit 
in a sucrose gradient can shift the sedimentation of part of the 
B subunit from the position of a B2 dimer (52 kDa) to that of 
an OC2P2 tretramer (130 kDa). In both of these experiments the 
aA156 subunit behaves as the wild-type CK2oc. Careful studies 
with the yeast two-hybrid system, that dwelled on the ques-
tion of the part of CK2oc involved in binding to the B subunit, 
reached the conclusion that the only dispensable regions were 
the amino and carboxyl terminal non-conserved regions [30]. 
The capturing of B by the inactive CK2ocA156 is also shown 
by its capacity to compete with CK2a for the B subunit. This 
competition is observed by an inhibition of the phosphoryla-
tion of casein or the specific CK2 peptide substrate when the 
inactive mutant is added to a mixture of wild-type recombi-
nant a and B subunits. The presence of aA156 decreases the 
effect of CK2B when this subunit is at low concentrations but 
the mutant does not alter the activity of cc. The effect of aA156 
on the phosphorylation activity is clearly due to competition 
for B with the wild-type subunit since it depends on the oc/ 
aA156 ratio and on the concentration of B available. Excess of 
B tends to eliminate the effect of the mutant. 
The inhibitory effects of aA156 on the phosphorylating ac-
tivity of the mixture of CK2oc and B subunits is not only seen 
with exogenous substrates but also with the autophosphoryl-
ation of the B subunit itself. This result suggests that the 
phosphorylation of B is mainly due to an intra-tetrameric 
reaction or that the formation of a complex with the inactive 
catalytic subunit blocks the access of the autophosphorylation 
site of the B subunit to the active CK2oc. 
CK2B acts as a negative regulator of calmodulin phospho-
rylation by CK2ot and phosphorylation of this protein sub-
strate is only seen in the absence of B [6,7]. Accordingly, with 
this substrate, the addition of aA156 to a mixture of a and B 
causes an activation in the phosphorylation of calmodulin. 
This result again demonstrates the capacitity of aA156 to se-
quester B and to compete with the wild-type oc subunit for this 
interaction. 
Previous studies have shown that there is very little disso-
ciation of the a and B subunits of the native CK2 holoenzyme 
[31]. Coincident with this observation is the result obtained 
that indicates that aA156 does not inhibit native CK2 purified 
from oocyte extracts. Also in agreement with this finding is 
the fact that a short preincubation of a and a limiting amount 
of B at 0°C considerably reduces the inhibition observed by 
addition of aA156. Conversely, preincubation of the aA156 
with B traps more of the regulatory subunit and leaves less 
available for the interaction with wild-type oc. These results 
also indicate that, under the conditions used, the formation of 
a stable complex by recombinant oc and B is not instantane-
ous. Even after 10 min of preincubation at 0°C, there is 
enough B available to interact with aA156, as can be seen by 
the fact that some inhibition by the mutant is observed in 
condition 2 of Fig. 3. 
The capacity of aA156 to scavange B with an affinity of the 
same order of magnitude as that of wild-type a can make this 
mutant very useful in exploring the physiological effects of the 
CK2B subunit in vivo in a similar fashion as dominant-neg-
ative mutants have been very important in defining the role of 
components of signal transducion cascades [32]. In this regard 
it is relevant to emphasize that CK2B has recently been shown 
to have a role that transcends its regulation of CK2oc activity. 
The CK2B activation of A-Raf [13,14] and the inhibition of 
mos [15] by this subunit have been reported to be antagonized 
by CK2oc and presumably would be also blocked by the aA156 
mutant. 
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